Case 2 – Advanced low-grade ovarian cancer with peritoneal implants

 

Authors

  • Annalisa Garbi Division of Gynecologic Oncology, European Institute of Oncology, Milan, Italy.
  • Maria Teresa Achilarre Division of Gynecologic Oncology, European Institute of Oncology, Milan, Italy.
  • Maria Cristina Petrella Division of Gynecologic Oncology, European Institute of Oncology, Milan, Italy.
  • Els Van Nieuwenhuysen Division of Gynecologic Oncology, Department of Gynaecology and Obstetrics, Leuven Cancer Institute, University Hospital of Leuven, Belgium
  • Ignace Vergote Division of Gynecologic Oncology, Department of Gynaecology and Obstetrics, Leuven Cancer Institute, University Hospital of Leuven, Belgium

DOI:

https://doi.org/10.19156/cbn.2016.0018

Keywords:

chemoresistance, cytoreductive surgery, invasive low-grade serous ovarian cancer, MEK inhibitors

Abstract

Low-grade serous carcinomas are a less common subtype of serous epithelial ovarian cancer. They differ from high-grade serous tumors in their immuno-histochemical profile, epidemiologic features, clinical behavior and molecular characteristics. This case report describes the clinical history of a young woman who underwent multiple surgical and medical treatments.